No abstract available
Publication types
-
Comparative Study
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived / adverse effects
-
Antibodies, Monoclonal, Murine-Derived / economics
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / economics
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor
-
Cost-Benefit Analysis
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / economics
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Doxorubicin / economics
-
Humans
-
Kaplan-Meier Estimate
-
Lymphoma, Follicular / drug therapy*
-
Lymphoma, Follicular / economics
-
Lymphoma, Follicular / genetics
-
Middle Aged
-
Polymerase Chain Reaction
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Prednisone / economics
-
Proportional Hazards Models
-
Remission Induction
-
Rituximab
-
Treatment Outcome
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
Vincristine / economics
-
Young Adult
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Biomarkers, Tumor
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone